42 providing medical treatment to increase and to potentiate a patient's effector cells to enhance immune capacity against lung cancer, cancer metastatic to the lung or refractory advanced malignancies, cancer, HIV infection, AIDS or other disease pathogens and/or prepare the immune system for lymphokine, cytokine or other biological response modifier administration
Trademark: 74723831
